13.12.2021 00:40:04 CET | Aqua Bio Technology ASA | Mandatory notification of
trade primary insiders

Aqua Bio Technology ASA - Primary insider Notifications

Reference is made to the stock exchange notice from Aqua Bio Technology ASA (the
"Company") regarding the completion of a private placement to raise NOK 12.89
million.

In the private placement Håvard Lindstrøm, CEO and primary insider the Company,
has been allocated 71 429 shares at a price of NOK 14 per share, through his
wholly owned company Ice Capital AS. Following such allocation, Håvard Lindstrøm
and related parties will, upon issuance of shares in the private placement, hold
416 348 shares in the Company, corresponding to an ownership stake of 2.0% of
the total outstanding shares in the Company.

Roger Hofseth, board member and primary insider of ABT, has been allocated 178
571 shares today at a price of NOK 14 per share, through his wholly owned
company RH Industri AS. Following such allocation, Roger Hofseth and related
parties will, upon issuance of shares in the private placement, hold 4 693 475
shares in the Company, corresponding to an ownership stake of 22.76% of the
total outstanding shares in the Company.

Jan Petterson, board member and primary insider of ABT, has been allocated 107
143 shares today at a price of NOK 14 per share. Following such allocation, Jan
Petterson and related parties will, upon issuance of shares in the private
placement, hold 4 543 028 shares in the Company, corresponding to an ownership
stake of 22.03% of the total outstanding shares in the Company.

Espen Halvard Dahl, a close associate of Board member Kristin Aase who is a
primary insider in the Company, has been allocated 71 429 shares at a price of
NOK 14. Following such allocation, Espen Halvard Dahl, Kjeveortoped Espen Dahl
AS and close associates (including Board member Kristin Aase) will, upon
issuance of shares in the private placement, hold 1 477 707 shares in the
company, corresponding to an ownership stake of 7.17% of the total outstanding
shares in the Company.

Further information is available in the attached forms.

****

For further information, please contact Håvard Lindstrøm, CEO, telephone +47 941
32 288.

This information is subject to the disclosure requirements in Regulation EU
596/2014 article 19 number 3 and the Norwegian Securities Trading Act § 5-12.

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
effective and they provide the cosmetics industry with natural alternatives to
traditional ingredients. ABT is also marketing and distributing natural skin
care products developed by partners towards consumers and professional users.
ABT's focus on commercialization and development of natural ingredients and
natural skin care products has been, and will continue to be, an important part
of the company's strategy going forward. Aqua Bio Technology is listed on
Euronext Expand.

 

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

 * Håvard Lindstrøm, 004794132288, hl@aquabiotech.no 

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/1060/1427/Download%20announcement
%20as%20PDF.pdf

Ice Capital AS.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/1060/1424/Ice%20Capital%20AS.pdf

RH Industri AS.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/1060/1425/RH%20Industri%20AS.pdf

EH Dahl Jan Petterson.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/1060/1426/EH%20Dahl%20%20Jan%20Pe
tterson.pdf